Dr Reddy's launches oncology injection in US

Moneycontrol Bureau

Generic drugs maker Dr Reddy's Laboratories on Tuesday said it has launched Zoledronic Acid injection 4mg/5ml in the US market following approval by the US Food and Drugs Administration. The injection is a copy of Novartis AG's Zometa, a drug used to strengthen bones in cancer patients. Don't Miss: Natco Pharma soars 12% on Nexavar case win Dr Reddy's Zoledronic Acid injection is available in a single use vial of concentrate, it said. Dr Reddy's shares were up over 1 percent at Rs 1,783.75 on NSE in morning trade. Also Read: Bears with inside info hammer NHPC shares 32% in 3 sessions